Product information

Current status:

Marketed

Current status date:

2005-12-23

Original market date: ^{See footnote 1}

2001-02-27

Product name:

SANDOZ ORPHENADRINE

DIN:

02243559 Electronic product monograph is not available

Company:

SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada J4B 1E6

Class:

Human

Dosage form(s):

Tablet (Extended-Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

12:20.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

M03BC01 ORPHENADRINE (CITRATE)

Active ingredient group (AIG) number:^{See footnote5}

0102078001